Combination therapy can prevent cytostatic resistance
Wednesday, November 25, 2015 - 11:10
in Health & Medicine
Researchers have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumor in children. The promising results of this experimental study are based on a combination of the drug temozolomid and other extant drugs that inhibit an enzyme instrumental in DNA repair in cancer cells.